PRESS-RELEASE ·Filed Apr 6, 2026
Press release · Earnings
Final — all horizons settled through T+60d ⚠ clustered
ORGO ▲ +8.93% at T+60d
NEUTRAL call +8.93% · α vs SPY -4.54% · entry $2.24 → $2.44
T+1d
+0.89%
call +0.89% · α +0.83%
$2.26
settled 7mo ago
T+5d
+6.25%
call +6.25% · α +2.12%
$2.38
settled 7mo ago
T+20d
+14.29%
call +14.29% · α +5.30%
$2.56
settled 6mo ago
T+60d
+8.93%
call +8.93% · α -4.54%
$2.44
settled 4mo ago
Price Chart
Loading chart...
Executive Summary
Organogenesis Holdings Inc. announced it will report its fiscal Q1 2026 results on May 7, 2026.
Key Facts
- Organogenesis Holdings Inc. announced it will report its fiscal Q1 2026 results on May 7, 2026.
Market Snapshot
Exchange
Nasdaq
Sector
Pharmaceutical Preparations
Investment Themes
Documents Analyzed
This report is based on 1 press release from GlobeNewswire.
| Document | Accession Number |
|---|---|
| PRESS-RELEASE Data (Synthetic) | press-3268357 |
3 reports for ORGO
Track record builds as more directional reports settle.
Filters
Rows
| Type | Now | ||||
|---|---|---|---|---|---|
Jul 27, 2026 13w ago | Press Release | $2.53 $0.9913 | ▼ −60.82% | ▼ −65.17% | $0.9038 (−64.28%) |
Jun 16, 2026 18w ago | 8-K | $2.34 $1.49 | ▼ −36.32% | ▼ −39.47% | $0.9038 (−61.38%) |
Apr 6, 2026 29w ago | Press Release | $2.24 $2.44 | ▲ +8.93% | ▼ −4.54% | $0.9038 (−59.65%) |
Showing 3 of 3
US Market Status
Market Open — Closes in 1h 34m
Subscribe to SecBot
Get Real-Time SEC Filing Intelligence
Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.
Create a free account Live analysis, Telegram alerts, watchlists and the MCP server for subscribers